Numerous in vitro and in vivo studies have demonstrated the anti-proliferative, pro-apoptotic, anti-angiogenic, and chemosensitizing effects of resveratrol on various types of cancer, including BC [151], by attenuating pro-inflammatory mediators through the modulation of NF-κB and STAT3 signaling in BC cells (Figure 7) [157,158]. Here, NFKB1 is linked to cancer.